244 related articles for article (PubMed ID: 34355022)
1. Annexin A3, a Calcium-Dependent Phospholipid-Binding Protein: Implication in Cancer.
Yang L; Lu P; Yang X; Li K; Qu S
Front Mol Biosci; 2021; 8():716415. PubMed ID: 34355022
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of annexin A3 inhibits tumor metastasis and decreases drug resistance in breast cancer.
Du R; Liu B; Zhou L; Wang D; He X; Xu X; Zhang L; Niu C; Liu S
Cell Death Dis; 2018 Jan; 9(2):126. PubMed ID: 29374148
[TBL] [Abstract][Full Text] [Related]
3. Annexin A3 promotes tumorigenesis and resistance to chemotherapy in hepatocellular carcinoma.
Pan QZ; Pan K; Weng DS; Zhao JJ; Zhang XF; Wang DD; Lv L; Jiang SS; Zheng HX; Xia JC
Mol Carcinog; 2015 Aug; 54(8):598-607. PubMed ID: 24375474
[TBL] [Abstract][Full Text] [Related]
4. Tumor-Suppressing Effect of Silencing of Annexin A3 Expression in Breast Cancer.
Kim JY; Jung EJ; Park HJ; Lee JH; Song EJ; Kwag SJ; Park JH; Park T; Jeong SH; Jeong CY; Ju YT; Lee YJ; Hong SC
Clin Breast Cancer; 2018 Aug; 18(4):e713-e719. PubMed ID: 29217453
[TBL] [Abstract][Full Text] [Related]
5. Annexin A3 depletion overcomes resistance to oxaliplatin in colorectal cancer via the MAPK signaling pathway.
Xu R; Yin J; Zhang Y; Zhang S
J Cell Biochem; 2019 Sep; 120(9):14585-14593. PubMed ID: 30998268
[TBL] [Abstract][Full Text] [Related]
6. Annexin A3 Knockdown Suppresses Lung Adenocarcinoma.
Liu YF; Liu QQ; Zhang YH; Qiu JH
Anal Cell Pathol (Amst); 2016; 2016():4131403. PubMed ID: 27995049
[TBL] [Abstract][Full Text] [Related]
7. Role of annexin A3 in breast cancer (Review).
Ozturk A
Mol Clin Oncol; 2022 Jun; 16(6):111. PubMed ID: 35620213
[TBL] [Abstract][Full Text] [Related]
8. The role of annexin A3 playing in cancers.
Wu N; Liu S; Guo C; Hou Z; Sun MZ
Clin Transl Oncol; 2013 Feb; 15(2):106-10. PubMed ID: 23011854
[TBL] [Abstract][Full Text] [Related]
9. Annexin A3 and cancer.
Liu C; Li N; Liu G; Feng X
Oncol Lett; 2021 Dec; 22(6):834. PubMed ID: 34712358
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of ANXA3 is an independent prognostic indicator in gastric cancer and its depletion suppresses cell proliferation and tumor growth.
Wang K; Li J
Oncotarget; 2016 Dec; 7(52):86972-86984. PubMed ID: 27894078
[TBL] [Abstract][Full Text] [Related]
11. Annexin A3 as a Prognostic Biomarker for Breast Cancer: A Retrospective Study.
Zhou T; Li Y; Yang L; Tang T; Zhang L; Shi J
Biomed Res Int; 2017; 2017():2603685. PubMed ID: 28497041
[TBL] [Abstract][Full Text] [Related]
12. Silencing of ANXA3 expression by RNA interference inhibits the proliferation and invasion of breast cancer cells.
Zhou T; Li Y; Yang L; Liu L; Ju Y; Li C
Oncol Rep; 2017 Jan; 37(1):388-398. PubMed ID: 27878264
[TBL] [Abstract][Full Text] [Related]
13. Cancer-associated fibroblasts contribute to cisplatin resistance by modulating ANXA3 in lung cancer cells.
Wang L; Li X; Ren Y; Geng H; Zhang Q; Cao L; Meng Z; Wu X; Xu M; Xu K
Cancer Sci; 2019 May; 110(5):1609-1620. PubMed ID: 30868675
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of annexin A3 blockade in sensitizing hepatocellular carcinoma to sorafenib and regorafenib.
Tong M; Che N; Zhou L; Luk ST; Kau PW; Chai S; Ngan ES; Lo CM; Man K; Ding J; Lee TK; Ma S
J Hepatol; 2018 Oct; 69(4):826-839. PubMed ID: 29885413
[TBL] [Abstract][Full Text] [Related]
15. The expression of ANXA3 and its relationship with the occurrence and development of breast cancer.
Zhou T; Liu S; Yang L; Ju Y; Li C
J BUON; 2018; 23(3):713-719. PubMed ID: 30003741
[TBL] [Abstract][Full Text] [Related]
16. Expression and prognostic relevance of annexin A3 in prostate cancer.
Köllermann J; Schlomm T; Bang H; Schwall GP; von Eichel-Streiber C; Simon R; Schostak M; Huland H; Berg W; Sauter G; Klocker H; Schrattenholz A
Eur Urol; 2008 Dec; 54(6):1314-23. PubMed ID: 18222597
[TBL] [Abstract][Full Text] [Related]
17. Application of Serum Annexin A3 in Diagnosis, Outcome Prediction and Therapeutic Response Evaluation for Patients with Hepatocellular Carcinoma.
Ma XL; Jiang M; Zhao Y; Wang BL; Shen MN; Zhou Y; Zhang CY; Sun YF; Chen JW; Hu B; Gong ZJ; Zhang X; Cao Y; Pan BS; Zhou J; Fan J; Yang XR; Guo W
Ann Surg Oncol; 2018 Jun; 25(6):1686-1694. PubMed ID: 29626309
[TBL] [Abstract][Full Text] [Related]
18. MiR‑221 and miR‑222 regulate cell cycle progression and affect chemosensitivity in breast cancer by targeting ANXA3.
Kim JY; Jung EJ; Kim JM; Son Y; Lee HS; Kwag SJ; Park JH; Cho JK; Kim HG; Park T; Jeong SH; Jeong CY; Ju YT
Exp Ther Med; 2023 Mar; 25(3):127. PubMed ID: 36845963
[TBL] [Abstract][Full Text] [Related]
19. MiR-340-5p is a potential prognostic indicator of colorectal cancer and modulates ANXA3.
Yang L; Men WL; Yan KM; Tie J; Nie YZ; Xiao HJ
Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4837-4845. PubMed ID: 30070320
[TBL] [Abstract][Full Text] [Related]
20. ANXA3/JNK Signaling Promotes Self-Renewal and Tumor Growth, and Its Blockade Provides a Therapeutic Target for Hepatocellular Carcinoma.
Tong M; Fung TM; Luk ST; Ng KY; Lee TK; Lin CH; Yam JW; Chan KW; Ng F; Zheng BJ; Yuan YF; Xie D; Lo CM; Man K; Guan XY; Ma S
Stem Cell Reports; 2015 Jul; 5(1):45-59. PubMed ID: 26095609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
